Doug Randall
Chief Operating Officer bei TENAX THERAPEUTICS, INC.
Profil
Doug Randall was the founder of Phyxius Pharma, Inc. which was founded in 2011, where he held the title of Chief Commercial Officer from 2011 to 2013.
He is currently the Executive VP-Commercial & Business Operations at Tenax Therapeutics, Inc. since 2013.
Prior to this, he was the Vice President-Commercial Operations at The Medicines Co. from 2005 to 2010.
He also held the title of Vice President-US Diabetes Marketing at Sanofi-Aventis Pharmaceuticals from 2003 to 2005.
Additionally, he was a Vice President-Sales at Aventis Pharmaceuticals, Inc. He received his undergraduate degree from the University of Rhode Island in 1982.
Aktive Positionen von Doug Randall
| Unternehmen | Position | Beginn |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Chief Operating Officer | 14.11.2013 |
Ehemalige bekannte Positionen von Doug Randall
| Unternehmen | Position | Ende |
|---|---|---|
Phyxius Pharma, Inc.
 Phyxius Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., Phyxius Pharma, Inc. provides pharmaceutical products. The private company is based in Chester, NJ. The company was founded by Doug Randall, Douglas Hay, John P. Kelley. Phyxius Pharma was acquired by Life Newco, Inc. on November 13, 2013 for $32.66 million. | Founder | 01.11.2013 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | 01.02.2010 |
| Sanofi-Aventis Pharmaceuticals | Corporate Officer/Principal | 01.03.2005 |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Sales & Marketing | - |
Ausbildung von Doug Randall
| University of Rhode Island | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TENAX THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
| Sanofi-Aventis Pharmaceuticals | |
Phyxius Pharma, Inc.
Phyxius Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., Phyxius Pharma, Inc. provides pharmaceutical products. The private company is based in Chester, NJ. The company was founded by Doug Randall, Douglas Hay, John P. Kelley. Phyxius Pharma was acquired by Life Newco, Inc. on November 13, 2013 for $32.66 million. | Health Technology |
